Therapeutic complications in acute myelogenous leukemia
Ness, P.M.; Perkins, H.A.
New England Journal of Medicine 301(10): 557
1979
ISSN/ISBN: 0028-4793 PMID: 287862 Document Number: 152951
Document emailed within 1 workday
Related Documents
Alsabti, E.A.; Taleb, A.M.; Raji, H.M.; Kalil, O.Z.; Saleh, K.A. 1979: Clinical trials in vaccination with leukemia associated antigens in acute myelogenous leukemia Japanese Journal of Experimental Medicine 49(3): 157-168Santos, G.W. 1988: Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia Cancer Detection and Prevention 12(1-6): 589-596
Dhingra, K.; Talpaz, M.; Kantarjian, H.; Ku, S.; Rothberg, J.; Gutterman, J.U.; Kurzrock, R. 1991: Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression Leukemia 5(3): 191-195
Shumak, K.H.; Baker, M.A.; Taub, R.N.; Coleman, M.S. 1980: Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 40(11): 4048-4052
Anderson, J.K.; Moore, J.O.; Metzgar, R.S. 1979: Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 39(12): 4810-4815
Lie, S.O. 1974: Acute myelogenous leukemia in children Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 94(32): 2232-2234
Gale, R.P.; Butturini, A. 1991: Strategies for acute myelogenous leukemia Bone Marrow Transplantation 7(Suppl 2): 58
Meisenberg, B. 1995: Treatment of acute myelogenous leukemia New England Journal of Medicine 332(25): 1718; Author Reply 1718-1719
Estey, E.H. 2002: Treatment of acute myelogenous leukemia Oncology 16(3): 343-352; 355-356; Discussion 357 362 365-366
Mittal, R.R.; Kullar, J.; Sethi, P.S. 2000: Skin changes in acute myelogenous leukemia Indian Journal of Dermatology Venereology and Leprology 66(5): 266-267
Gale, R.P.; Foon, K.A. 1987: Therapy of acute myelogenous leukemia Seminars in Hematology 24(1): 40-54
Ghaddar, H.; Anderlini, P.; Estey, E. 1995: Treatment of acute myelogenous leukemia New England Journal of Medicine 332(25): 1717-1718; Author Reply 1718-1719
Mohanakumar, T.; Russell, E.C.; Metzgar, R.S.; Dunn, N.; Phibbs, M.; McWilliams, N.B.; Maurer, H.M. 1979: Human acute myelogenous leukemia antigens defined by simian antisera: evidence for leukemia-associated antigens distinct from immune response-associated alloantigens Journal of the National Cancer Institute 62(5): 1163-1167
Suciu, S.; Solbu, G.; Zittoun, R.; Hayat, M.; Willemze, R.; de Witte, T.; Mandelli, F. 1991: Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA Bone Marrow Transplantation 7(Suppl 2): 34
Dohy, H.; Kyo, T. 1989: Progress in the treatment of acute myelogenous leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(5): 1976-1981
Advani, A.S. 2005: C-kit as a target in the treatment of acute myelogenous leukemia Current Hematology Reports 4(1): 51-58
Champlin, R.E.; Gajewski, J.L.; Golde, D.W. 1989: Treatment of acute myelogenous leukemia in the elderly Seminars in Oncology 16(1): 51-56
Arai, C.; Tsuzaki, Y.; Nagano, Y. 1999: In vivo therapeutic effects of IFN-gamma on human myelogenous leukemia in a severe combined immunodeficiency mouse model In Vivo 13(6): 445-451
Lerede, T.; Bassan, R.; Rossi, A.; Di Bona, E.; Rossi, G.; Pogliani, E.M.; Motta, T.; Torri, V.; Buelli, M.; Comotti, B.; Viero, P.; Rambaldi, A.; Cortelazzo, S.; Rodeghiero, F.; Barbui, T. 1996: Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphoma Haematologica 81(5): 442-449
Preisler, H.D.; Raza, A. 1992: Cell cycle studies in acute myelogenous leukemia Leukemia 6(8): 751-753